SEC Company Response from SELLAS Life Sciences Group, Inc. (SLS) (CIK 0001390478) (SLS) — Apr 27, 2021
SELLAS Life Sciences Group, Inc. (SLS) (CIK 0001390478)
Date: April 27, 2021 · CIK: 0001390478 · Accession: 0001104659-21-055790
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-255318
Letter
Via EDGAR United States Securities and Exchange Commission Division of Corporate Finance Re: SELLAS Life Sciences Group, Inc. Registration Statement on Form S-3 File No. 333-255318 Acceleration Request
Dear Ms. Schwartz,
Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, SELLAS Life Sciences Group, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-255318), so that it may become effective at 5:00 p.m. (Washington, D.C. time) on Thursday, April 29, 2021, or as soon thereafter as practicable.
Please call Daniel A. Bagliebter, of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any comments or questions regarding the Registration Statement.
Very truly yours,
SELLAS Life Sciences Group, Inc.
Show Raw Text
CORRESP
1
filename1.htm
SELLAS Life Sciences Group, Inc.
7 Times Square, Suite 2503
New York, New York 10036
April 27, 2021
Via
EDGAR
Margaret Schwartz
United States Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: SELLAS Life Sciences Group, Inc.
Registration Statement on Form S-3
File No. 333-255318
Acceleration Request
Dear Ms. Schwartz,
Pursuant to Rule 461
of Regulation C promulgated under the Securities Act of 1933, as amended, SELLAS Life Sciences Group, Inc. (the “Registrant”)
hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-255318), so that it may
become effective at 5:00 p.m. (Washington, D.C. time) on Thursday, April 29, 2021, or as soon thereafter as practicable.
Please call Daniel A. Bagliebter,
of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any comments or questions regarding
the Registration Statement.
Very truly yours,
SELLAS Life Sciences Group, Inc.
/s/ Angelos M. Stergiou
By: Angelos M. Stergiou, M.D., Sc.D., h.c.
Its: President and Chief Executive Officer
cc: Barbara A. Wood, SELLAS Life Sciences Group, Inc.
Daniel A. Bagliebter, Esq., Mintz, Levin, Cohn,
Ferris, Glovsky and Popeo, P.C.